REVBIO, INC. — Form D/A
REVBIO, INC. of LOWELL, MA, a company, filed a Form D amendment with the SEC on 2022-05-24. The offering totals $10.2M, of which $9.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-05-24
- Form: D/A
- Accession: 0001763734-22-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.2M
- Amount sold: $9.0M
- Remaining: $1.2M
- Investors: 34
- Date of first sale: 2021-06-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-402611
Issuer
- Name: REVBIO, INC.
- CIK: 0001763734
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 600 SUFFOLK STREET, LOWELL, MA, 01854
- Phone: 617-947-6246
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| GEORGE GRAYSON KAY | Director | LOWELL, MA |
| BRIAN HESS | Director | LOWELL, MA |
| BRIAN HESS | Executive Officer | LOWELL, MA |
| KEVIN GRAYSON FOLEY | Director | LOWELL, MA |
| GEORGE KAY | Director | LOWELL, MA |
| D. GRAYSON ALLEN | Director | LOWELL, MA |
| D. GRAYSON ALLEN | Executive Officer | LOWELL, MA |
Other filings by this issuer (5)
More